Dihydrolycorine
Based on 1 publication(s) in Google Scholar
Dihydrolycorine, isolated from Lycoris radiate Herb, is an inhibitor of protein synthesis in eukarytic cells by inhibiting the peptide bone formation step.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 98.81%
- No. CAS: 6271-21-2
- Fòrmula: C16H19NO4
- Peso molecular:289.33
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
-
Solvente y solubilidad
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-N0455AS2
L-Arginine-d7 hydrochloride
-
HY-N0455AS6
L-Arginine-13C6 hydrochloride
-
HY-100113
Buloxibutid
-
HY-N7028
Withanolide A
-
HY-W107464
G6PDi-1
-
HY-N0401
Ligustilide
-
HY-P1540
Angiotensin III, human, mouse
-
HY-100113R
Buloxibutid (Standard)
-
HY-156054
N-Hydroxy riluzole
-
HY-117281S
Moexipril-d5
-
HY-W002108
3,4-Dihydroquinolin-2(1H)-one
-
HY-17436S1
Clevidipine-d7
Publications Citing Use of MedChemExpress (MCE) Dihydrolycorine
More
Actividad biológica
Protein synthesis[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
>10 μM
Compound: 8, alpha-dihydrolycorine
|
Growth inhibition of proapoptotic stimuli-resistant human A549 cells after 72 hrs by MTT assay
Growth inhibition of proapoptotic stimuli-resistant human A549 cells after 72 hrs by MTT assay
|
[PMID: 19788245] |
| B16-F10 | IC50 |
>10 μM
Compound: 8, alpha-dihydrolycorine
|
Growth inhibition of proapoptotic stimuli-sensitive mouse B16F10 cells after 72 hrs by MTT assay
Growth inhibition of proapoptotic stimuli-sensitive mouse B16F10 cells after 72 hrs by MTT assay
|
[PMID: 19788245] |
| Hs 683 | IC50 |
>10 μM
Compound: 8, alpha-dihydrolycorine
|
Growth inhibition of proapoptotic stimuli-sensitive human Hs683 cells after 72 hrs by MTT assay
Growth inhibition of proapoptotic stimuli-sensitive human Hs683 cells after 72 hrs by MTT assay
|
[PMID: 19788245] |
| KB | IC50 |
>50 μg/mL
Compound: 14
|
Cytotoxicity against human KB cells assessed as reduction in cell viability
Cytotoxicity against human KB cells assessed as reduction in cell viability
|
[PMID: 31515186] |
| L6 | IC50 |
26.99 μg/mL
Compound: 14
|
Cytotoxicity against rat L6 cells assessed as reduction in cell viability
Cytotoxicity against rat L6 cells assessed as reduction in cell viability
|
[PMID: 31515186] |
| SK-MEL-28 | IC50 |
>10 μM
Compound: 8, alpha-dihydrolycorine
|
Growth inhibition of proapoptotic stimuli-resistant human SK-MEL-28 cells after 72 hrs by MTT assay
Growth inhibition of proapoptotic stimuli-resistant human SK-MEL-28 cells after 72 hrs by MTT assay
|
[PMID: 19788245] |
| U-373MG ATCC | IC50 |
>10 μM
Compound: 8, alpha-dihydrolycorine
|
Growth inhibition of proapoptotic stimuli-resistant human U373 cells after 72 hrs by MTT assay
Growth inhibition of proapoptotic stimuli-resistant human U373 cells after 72 hrs by MTT assay
|
[PMID: 19788245] |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 6271-21-2
-
Appearance Solid
-
Peso molecular 289.33
-
Fòrmula C16H19NO4
-
Color White to off-white
-
SMILES
O[C@H]1[C@]2([H])[C@]3([H])N(CC[C@]3([H])C[C@@H]1O)CC4=CC(OCO5)=C5C=C24
-
Structure Classification
-
Initial Source
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Antiviral Res
Discovery of hepatitis B virus subviral particle biogenesis inhibitors from a bioactive compound library. [Abstract]2024 Aug:228:105955. PMID: 38964614
Solvente y solubilidad
DMSO : 12.5 mg/mL (43.20 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 1.25 mg/mL (4.32 mM); Clear solution
This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 1.25 mg/mL (4.32 mM); Clear solution
This protocol yields a clear solution of ≥ 1.25 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (12.5 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureza y Documentación
-
Ficha de datos (276 KB)
-
SDS (419 KB)
- English - EN (419 KB)
- Français - FR (419 KB)
- Deutsch - DE (419 KB)
- Norwegian - NO (419 KB)
- Español - ES (419 KB)
- Swedish - SV (419 KB)
- Italian - IT (419 KB)
- Korean - KR (419 KB)
- Portuguese - PT (419 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Jimenez A, et al. Inhibitors of protein synthesis in eukarytic cells. Comparative effects of some amaryllidaceae alkaloids. Biochim Biophys Acta. 1976 Mar 17;425(3):342-8. [Content Brief]
[2]. Chen BY, et al. [Hypotensive effect of dihydrolycorine]. Zhongguo Yao Li Xue Bao. 1993 Jan;14(1):45-9. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.4562 mL | 17.2812 mL | 34.5625 mL | 86.4062 mL |
| 5 mM | 0.6912 mL | 3.4562 mL | 6.9125 mL | 17.2812 mL | |
| 10 mM | 0.3456 mL | 1.7281 mL | 3.4562 mL | 8.6406 mL | |
| 15 mM | 0.2304 mL | 1.1521 mL | 2.3042 mL | 5.7604 mL | |
| 20 mM | 0.1728 mL | 0.8641 mL | 1.7281 mL | 4.3203 mL | |
| 25 mM | 0.1382 mL | 0.6912 mL | 1.3825 mL | 3.4562 mL | |
| 30 mM | 0.1152 mL | 0.5760 mL | 1.1521 mL | 2.8802 mL | |
| 40 mM | 0.0864 mL | 0.4320 mL | 0.8641 mL | 2.1602 mL |
Dihydrolycorine Related Classifications
HY-N2403 Related Classifications
Powered by Bioz